Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Inflammasome targeting with an NLRP3 agonist therapy is f... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Inflammasome targeting with an NLRP3 agonist therapy is feasible but ineffective in murine hepatocellular carcinoma models with liver damage
0
Authors
Zhangya Pu
10 more
Zhangya Pu
•
Zelong Liu
8 more
•
Dan Duda
Published
June 23, 2022
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Internal Medicine
Cancer
Show all topics
DOI
10.1101/2022.06.23.497362
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Internal Medicine
Cancer
Show all topics
DOI
10.1101/2022.06.23.497362
License
CC-BY
Other Formats
PDF
